Tori Marsh - March 30, 2017
Working with prescription drugs every day, I constantly find myself pausing over their obscure names that are oftentimes impossible to pronounce. Xeljanz? Idarucizumab? Tecfidera? How did these crazy names come to be, and who can we blame? I was interested, so I went down the rabbit hole…
Drugs have (at least) three names.
Right when a drug is developed, the naming process begins, starting with the chemical name. See More
Roni Shye - March 23, 2016
Nearly 52.5 million people in the US have arthritis, according to an estimate from the CDC (Centers for Disease Control and Prevention).
Rheumatoid arthritis one of the most common types, and a new drug has just been approved to help make treatment easier. A new, extended-release form of Xeljanz (tofacitinib) recently received approval from the FDA to treat moderate to severe rheumatoid arthritis.
What is Xeljanz XR used for?
Xeljanz XR is recommended for adult patients with moderately to severely active rheumatoid arthritis—and who have had a poor response to methotrexate, or can no longer tolerate it. See More
Roni Shye - December 30, 2014
You may be unfamiliar with the terms biologics or biosimilars but if you watch television you may have seen a commercial for them and not even know it! For example – the popular arthritis or Crohn’s medications Enbrel and Humira are biologics.
Biologics are medications that are typically expensive and usually obtained from a specialty pharmacy. Biologics are generally not used as first line treatment but instead considered by your doctor after other less expensive treatment options have been tried and failed. See More
Roni Shye - September 19, 2014
A 2014 comes to a close, we should be thinking about what to expect for 2015. The start of a new year is a time for new challenges, new goals, and inevitably, a new prescription formulary.
What does this mean for you?
Express Scripts has actually decided to add a medication back to their national preferred formulary. When it comes to drugs that treat inflammatory conditions like arthritis, psoriasis, and ulcerative colitis, you’ll actually have another option this year. See More
Roni Shye - November 13, 2013
Express Scripts and Caremark have removed certain medications from their formulary starting in January 2014. These companies handle prescription benefits for more than 200 million Americans, so your prescription coverage will likely be changing in the new year.
Over the next couple of weeks, we’ll be reviewing which prescriptions will no longer be covered and the suggested alternatives to give you a better picture of your options. See More
Elizabeth Davis - October 29, 2013
For many Americans with health insurance, more than 50 popular brand-name drugs may no longer be covered starting in January 2014. Express Scripts and Caremark, companies that handles pharmacy benefits for more than 200 million Americans, are removing almost 50 brands from their formularies at the end of 2013. More information is below.
What are Express Scripts and Caremark?
Express Scripts and Caremark are companies that administer prescription drug benefits for many health insurance companies and Tricare. See More